 |
Varicella Zoster Immune Globulin (Human) |
|---|---|
| Trade Name | Varizig |
| Orphan Indication | Passive immunization for the treatment of exposed, susceptible individuals who are at risk of complications from varicella |
| USA Market Approval | USA |
| USA Designation Date | 2006-11-07 00:00:00 |
| Sponsor | Cangene bioPharma, Inc.;155 Innovation Drive, Winnipeg;Manitoba R3T5Y3 |
